title: [Results of nutrition diagnostic studies in patients with bronchial cancer].
abstract: A group of 71 patients with bronchial carcinomas are submitted to nutritional assessment in this trial. A 6-point valuation scan from Schmoz et al. for the nutritional assessment is used. Especially the results of protein assessment and the skin tests with 4 recall antigens are worked out. These results are compared with reference ranges. In the pathological values, both the protein assessment and the skin tests are classified in 3 interference degrees. In the following interpretation, the group of patients are subdivided in one group, which undergoes conservative therapy (26 patients) and a second one, which is treated operationally (45 patients). The results showed that more than half of the patients had disturbed nutrition indices, more than 2/3 showed disturbed protein status and more than 90% of the patients showed pathological results in the skin tests.
authors.affiliation: BKH Schwerin, Akademie für Arztliche Fortbildung.
authors.forename: K
authors.initials: K
authors.lastname: Domnisch
authors.forename: P
authors.initials: P
authors.lastname: Freesen
authors.forename: E
authors.initials: E
authors.lastname: Kuhrt
authors.forename: P O
authors.initials: PO
authors.lastname: Willroth
authors.forename: H
authors.initials: H
authors.lastname: Storm
authors.forename: H
authors.initials: H
authors.lastname: Marin
mesh_terms: D002283:Carcinoma, Bronchogenic / Q000150:complications* / Q000473:pathology; D006452:Hemoglobinometry; D006801:Humans; D007428:Intradermal Tests; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D009752:Nutritional Status; D011502:Protein-Energy Malnutrition / Q000175:diagnosis*; D012709:Serum Albumin / Q000378:metabolism; D012885:Skinfold Thickness; D014168:Transferrin / Q000378:metabolism
chemical_list: D012709:Serum Albumin; D014168:Transferrin
vernacular_title: Ernährungsdiagnostische Untersuchungsergebnisse bei Patienten mit Bronchialkarzinom.